The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs

Programmed death-ligand 1 (PD-L1), which is expressed on many cancer cells, interacts with PD1 expressed on the surface of T cells, inhibiting the T cells and blocking the antitumor immune response. Expression of PD-L1 in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has not been studied....

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seung Tae, Ha, Sang Yun, Lee, Sujin, Ahn, Soomin, Lee, Jeeyun, Park, Se Hoon, Park, Joon Oh, Lim, Ho Yeong, Kang, Won Ki, Kim, Kyoung-Mee, Park, Young Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780123/
https://www.ncbi.nlm.nih.gov/pubmed/26958083
http://dx.doi.org/10.7150/jca.13711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780123/
https://www.ncbi.nlm.nih.gov/pubmed/26958083
http://dx.doi.org/10.7150/jca.13711

Ejemplares similares